Risk factors
Zura Bio (ZURA) risk factors
Item 1A of every Zura Bio Ltd. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors77 risks8 new7 dropped22 reworded
Clinical trials for ZB Assets face risks from prior trial translation and trial design changes in the TibuSHIELD study. International trade policies and new tariffs create supply chain and operational uncertainties. An internal audit subcommittee review regarding BAFFX17 and Stone Peach adds potential financial and reputational risks.
Filed Mar 19, 2026 - FY2024 10-K risk factors76 risks
Clinical-stage biopharmaceutical company with no approved products, generating zero revenue and significant net losses.
Filed Mar 25, 2025